OH2 Oncolytic Viral Therapy in Non-Muscle-Invasive Bladder Cancer
Clinical trial NCT05232136 · RECRUITING
Trial details
- NCT number
- NCT05232136
- Sponsor
- Binhui Biopharmaceutical Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-07-11
- Primary completion
- 2025-06-01
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.